These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32461067)

  • 1. Microbicidal actives with virucidal efficacy against SARS-CoV-2.
    Ijaz MK; Whitehead K; Srinivasan V; McKinney J; Rubino JR; Ripley M; Jones C; Nims RW; Charlesworth B
    Am J Infect Control; 2020 Aug; 48(8):972-973. PubMed ID: 32461067
    [No Abstract]   [Full Text] [Related]  

  • 2. A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.
    Ren YR; Golding A; Sorbello A; Ji P; Chen J; Saluja B; Witzmann K; Arya V; Reynolds KS; Choi SY; Nikolov NP; Sahajwalla C
    J Clin Pharmacol; 2020 Aug; 60(8):954-975. PubMed ID: 32469437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroquine as a prophylactic agent against COVID-19?
    Gendrot M; Javelle E; Clerc A; Savini H; Pradines B
    Int J Antimicrob Agents; 2020 Jun; 55(6):105980. PubMed ID: 32294495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
    Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD
    J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. John-Arne Røttingen.
    Mullard A
    Nat Rev Drug Discov; 2020 May; 19(5):302-303. PubMed ID: 32286497
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19: The Need for Immunoprevention at Industrial Scale.
    Halstead SB
    Am J Trop Med Hyg; 2020 Jun; 102(6):1151. PubMed ID: 32274985
    [No Abstract]   [Full Text] [Related]  

  • 7. [SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
    Ladoux A; Azoulay S; Dani C
    Med Sci (Paris); 2020; 36(6-7):555-558. PubMed ID: 32558640
    [No Abstract]   [Full Text] [Related]  

  • 8. World War against COVID-19: How strong is our armamentarium?
    Ramachandran V; Marimuthu RR; Chinnambedu RS
    Med J Malaysia; 2020 May; 75(3):314-315. PubMed ID: 32467555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19: Small-Molecule Clinical Trials Landscape.
    Ferreira LLG; Andricopulo AD
    Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
    [No Abstract]   [Full Text] [Related]  

  • 10. Emergence of novel coronavirus and progress toward treatment and vaccine.
    Khan MM; Noor A; Madni A; Shafiq M
    Rev Med Virol; 2020 Jul; 30(4):e2116. PubMed ID: 32495979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging the advances in HIV for COVID-19.
    McMahon JH; Hoy JF; Kamarulzaman A; Bekker LG; Beyrer C; Lewin SR
    Lancet; 2020 Oct; 396(10256):943-944. PubMed ID: 33010825
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigating hypothiocyanite against SARS-CoV-2.
    Cegolon L
    Int J Hyg Environ Health; 2020 Jun; 227():113520. PubMed ID: 32305009
    [No Abstract]   [Full Text] [Related]  

  • 13. Responding to Covid-19 - A Once-in-a-Century Pandemic?
    Gates B
    N Engl J Med; 2020 Apr; 382(18):1677-1679. PubMed ID: 32109012
    [No Abstract]   [Full Text] [Related]  

  • 14. Audio Interview: Approaches to Covid-19 Vaccines and Antivirals.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Apr; 382(16):e58. PubMed ID: 32320592
    [No Abstract]   [Full Text] [Related]  

  • 15. An Urgent Need for "Common Cold Units" to Study COVID-19.
    Halstead SB
    Am J Trop Med Hyg; 2020 Jun; 102(6):1152-1153. PubMed ID: 32274988
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2.
    Zhang Y; Kutateladze TG
    Nat Commun; 2020 Jun; 11(1):2920. PubMed ID: 32523109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination prevention for COVID-19.
    Cohen MS; Corey L
    Science; 2020 May; 368(6491):551. PubMed ID: 32381692
    [No Abstract]   [Full Text] [Related]  

  • 18. Current development of COVID-19 diagnostics, vaccines and therapeutics.
    Zhang N; Li C; Hu Y; Li K; Liang J; Wang L; Du L; Jiang S
    Microbes Infect; 2020; 22(6-7):231-235. PubMed ID: 32387332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
    Nisole S; Saulnier A; Gatignol A
    Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
    [No Abstract]   [Full Text] [Related]  

  • 20. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.